NASDAQ:RXRX | Operating Income | RECURSION PHARMACEUTICALS, INC.

Complete source-backed operating income history.

Available history
2019-12-31 to 2026-06-30
Data captured

Historical Operating Income

DateOperating Income
2026-06-30-$134.97M
2026-03-31-$128.51M
2025-12-31-$108.33M
2025-09-30-$172.2M
2025-06-30-$176.23M
2025-03-31-$191.37M
2024-12-31-$183.77M
2024-09-30-$98.35M
2024-06-30-$100.54M
2024-03-31-$96.34M
2023-12-31-$98.93M
2023-09-30-$99.55M
2023-06-30-$81.72M
2023-03-31-$69.87M
2022-12-31-$60.98M
2022-09-30-$62.57M
2022-06-30-$66.19M
2022-03-31-$55.98M
2021-12-31-$64.96M
2021-09-30-$46.4M
2021-06-30-$40.93M
2021-03-31-$30.48M
2020-12-31-$25.58M
2020-09-30-$22.47M
2020-06-30-$18.22M
2020-03-31-$18.34M

Annual Operating Income

DateOperating Income
2025-12-31-$648.13M
2024-12-31-$479M
2023-12-31-$350.06M
2022-12-31-$245.73M
2021-12-31-$182.78M
2020-12-31-$84.62M
2019-12-31-$62.44M

Research interface only. Not investment advice. Prices are a checked-in snapshot, not live quotes.